SEC Form 4 · accession 0001209191-16-134439
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Jul 27, 2016
Accepted (ET)
Jul 29, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2016 | M | 1,750 | $20.70 | A | 4,456 | D | |
| Common Stock | Jul 27, 2016 | M | 1,162 | $24.47 | A | 5,618 | D | |
| Common StockF2 | Jul 27, 2016 | S | 2,912 | $55.0062 | D | 2,706 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3 | $20.70 | Jul 27, 2016 | M | 1,750 | D | — | Dec 2, 2023 | Common Stock | 1,750 | 4,000 | D |
| Stock Option (right to buy)F4 | $24.47 | Jul 27, 2016 | M | 1,162 | D | — | Mar 3, 2024 | Common Stock | 1,162 | 3,012 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.
- F2The range in prices for the transaction reported on this line was $55.00 to $55.04. The average weighted price was $55.0062. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- F4This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.